UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

Journal of internal medicine, 2004-09, Vol.256 (3), p.240-246

2004

Volltextzugriff (PDF)

Transfer of omega‐3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid‐rich omega‐3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study

Journal of internal medicine, 2014-04, Vol.275 (4), p.428-436

2014

Volltextzugriff (PDF)

Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study

Journal of Alzheimer's disease, 2021-01, Vol.83 (3), p.1291-1301

2021

Volltextzugriff (PDF)

Vitamin B 12 and folate in relation to the development of Alzheimer’s disease

Neurology, 2001-05, Vol.56 (9), p.1188-1194

2001

Volltextzugriff (PDF)

High tau levels in cerebrospinal fluid predict rapid decline and increased dementia mortality in Alzheimer's disease

Dementia and geriatric cognitive disorders, 2014-01, Vol.37 (3-4), p.196-206

2014

Volltextzugriff (PDF)

Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease

Dementia and geriatric cognitive disorders, 2007-01, Vol.24 (4), p.247-252

2007

Volltextzugriff (PDF)

Serum cystatin C and the risk of Alzheimer disease in elderly men

Neurology, 2008-09, Vol.71 (14), p.1072-1079

2008

Volltextzugriff (PDF)

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

Journal of Alzheimer's disease, 2012-01, Vol.32 (2), p.273-276

2012

Volltextzugriff (PDF)

Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Journal of Alzheimer's disease, 2015-01, Vol.48 (2), p.403-410

2015

Volltextzugriff (PDF)

SUN-LB035: Does APOE4 Carriership Influence Potential Omega-3 Fatty Acid Treatment Effects on Cognition or Psychiatric Status in Patients With Mild to Moderate Alzheimer’S Disease: The Omegad Study

Clinical nutrition (Edinburgh, Scotland), 2015-09, Vol.34, p.S247-S248

2015

Volltextzugriff (PDF)

SUN-LB030: Does Fatty Acid Composition in Subcutaneous Fat Differ Between Patients With Alzheimer’s Disease and their Cohabiting Relatives?

Clinical nutrition (Edinburgh, Scotland), 2015-09, Vol.34, p.S245-S246

2015

Volltextzugriff (PDF)

The effect of nutritional intervention in elderly subjects residing in group-living for the demented

European journal of clinical nutrition, 2002-03, Vol.56 (3), p.221-227

2002

Volltextzugriff (PDF)

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Dementia and geriatric cognitive disorders, 2010-01, Vol.29 (3), p.204-212

2010

Volltextzugriff (PDF)

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Acta neurologica Scandinavica, 2010-10, Vol.122 (4), p.270-277

2010

Volltextzugriff (PDF)

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers

Journal of Alzheimer's disease, 2013-01, Vol.35 (4), p.697-713

2013

Volltextzugriff (PDF)

DHA-rich n–3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study

The American journal of clinical nutrition, 2017-10, Vol.106 (4), p.1157-1165

2017

Volltextzugriff (PDF)

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Acta neurologica Scandinavica, 2010-03, Vol.121 (3), p.186-193

2010

Volltextzugriff (PDF)

Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography

Dementia and geriatric cognitive disorders extra, 2013-01, Vol.3 (1), p.472-481

2013

Volltextzugriff (PDF)

Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease

Molecular and cellular neuroscience, 2021-07, Vol.114, p.103641-103641, Article 103641

2021

Volltextzugriff (PDF)

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study

Journal of Alzheimer's disease, 2019-01, Vol.69 (1), p.189-197

2019

Volltextzugriff (PDF)

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study

The journal of clinical psychiatry, 2009-06, Vol.70 (6), p.922-931

2009

Volltextzugriff (PDF)

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia

Journal of Alzheimer's disease, 2013-01, Vol.33 (1), p.45-53

2013

Volltextzugriff (PDF)

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study

PloS one, 2012-04, Vol.7 (4), p.e35425-e35425

2012

Volltextzugriff (PDF)

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

Journal of Alzheimer's disease, 2015-01, Vol.48 (3), p.805-812

2015

Volltextzugriff (PDF)

Nutrition education for care staff and possible effects on nutritional status in residents of sheltered accomodation

European journal of clinical nutrition, 2005-08, Vol.59 (8), p.947-954

2005

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(164)
Tagungsberichte
(9)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(118)
Science & Technology
(109)
Life Sciences & Biomedicine
(100)
Medicin Och Hälsovetenskap
(100)
Aged
(93)
Male
(85)
Female
(82)
Neurosciences & Neurology
(67)
Biological And Medical Sciences
(57)
Aged, 80 And Over
(56)
Middle Aged
(54)
Alzheimer's Disease
(52)
Medical Sciences
(50)
Neurology
(49)
Neurosciences
(38)
Alzheimer Disease - Genetics
(36)
Clinical Neurology
(35)
Dementia
(30)
Alzheimer Disease - Cerebrospinal Fluid
(25)
Apolipoproteins E - Genetics
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

Transfer of omega‐3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid‐rich omega‐3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study

Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study

Vitamin B 12 and folate in relation to the development of Alzheimer’s disease

High tau levels in cerebrospinal fluid predict rapid decline and increased dementia mortality in Alzheimer's disease

Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease

Serum cystatin C and the risk of Alzheimer disease in elderly men

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis

SUN-LB035: Does APOE4 Carriership Influence Potential Omega-3 Fatty Acid Treatment Effects on Cognition or Psychiatric Status in Patients With Mild to Moderate Alzheimer’S Disease: The Omegad Study

SUN-LB030: Does Fatty Acid Composition in Subcutaneous Fat Differ Between Patients With Alzheimer’s Disease and their Cohabiting Relatives?

The effect of nutritional intervention in elderly subjects residing in group-living for the demented

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers

DHA-rich n–3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography

Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

Nutrition education for care staff and possible effects on nutritional status in residents of sheltered accomodation

Suchergebnisse filtern